Zobrazeno 1 - 10
of 12
pro vyhledávání: '"James Gerson"'
Autor:
Srilakshmi Vallabhaneni, Srinath Adusumalli, Jingyi Wu, Peter W. Groeneveld, James Gerson, Rupal P. O’Quinn
Publikováno v:
Cardio-Oncology, Vol 10, Iss 1, Pp 1-8 (2024)
Abstract Background First generation Bruton tyrosine kinase inhibitors (BTKi) such as ibrutinib have been associated with cardiovascular toxicities. Newer generation BTKi (e.g.,acalabrutinib and zanabrutinib) have been associated with lower incidence
Externí odkaz:
https://doaj.org/article/b9988e8aeadc40d3993aea05696a6944
Autor:
Nausheen Ahmed, Swetha Kambhampati, Mehdi Hamadani, Natalie Grover, Mazyar Shadman, Frederick Locke, James Gerson, Matthew J. Frank, L. Elizabeth Budde, Michael Wang, Zhen-Huan Hu, Ana Nunes, David Dalton, Ioana Kloos, Daniel Lee, Hairong Xu, Marcelo Pasquini, Alex F. Herrera
Publikováno v:
HemaSphere, Vol 7, p e43327c1 (2023)
Externí odkaz:
https://doaj.org/article/d985d6a9077240fe831b6d80cdd69b0d
Autor:
Jakub Svoboda, Steven M. Bair, Daniel J. Landsburg, Sunita Dwivedy Nasta, Sarah J. Nagle, Stefan K. Barta, Nadia Khan, Joanne Filicko-O'Hara, Sameh Gaballa, Lauren Strelec, Elise Chong, Sheryl Mitnick, Terease S. Waite, Cara King, Hatcher Ballard, Matthew Youngman, James Gerson, John P. Plastaras, Amit Maity, Agata M. Bogusz, Stacy S. Hung, Hisae Nakamura, Reza Nejati, Christian Steidl, Megan Lim, Marco Ruella, Stephen J. Schuster
Publikováno v:
Haematologica, Vol 106, Iss 6 (2020)
We conducted a phase I/II multicenter trial using 6 cycles of brentuximab vedotin (BV) in combination with rituximab, cyclophosphamide, doxorubicin, and prednisone (R-CHP) for treatment of patients with CD30-positive (+) B-cell lymphomas. Thirty-one
Externí odkaz:
https://doaj.org/article/6889546d44be4604bfd437aa26536340
Autor:
Marco Ruella, Patrizia Porazzi, Stephen J. Schuster, James Gerson, Sara Cherry, David C. Schultz, Kanupriya Whig, Yunlin Zhang, Xueqing Maggie Lu, Simon F. Lacey, Wan-Jung Chang, Joseph A. Fraietta, Sarah E. Church, Khrystyna North, Elise A. Chong, Saar Gill, Jakub Svoboda, Katherine D. Cummins, Kimberly V. Amelsberg, Nicholas Yang, Inkook Chun, Seok Jae Hong, Hatcher J. Ballard, Ruchi Patel, Christopher Tor Sauter, Raymone Pajarillo, Guido Ghilardi, Puneeth Guruprasad, Yong Gu Lee
Supplementary Figure from Modulation of BCL-2 in Both T Cells and Tumor Cells to Enhance Chimeric Antigen Receptor T-cell Immunotherapy against Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d63f43f4903bc7d8bbd7a04cf8ac881
https://doi.org/10.1158/2159-8290.22541380.v1
https://doi.org/10.1158/2159-8290.22541380.v1
Autor:
Marco Ruella, Patrizia Porazzi, Stephen J. Schuster, James Gerson, Sara Cherry, David C. Schultz, Kanupriya Whig, Yunlin Zhang, Xueqing Maggie Lu, Simon F. Lacey, Wan-Jung Chang, Joseph A. Fraietta, Sarah E. Church, Khrystyna North, Elise A. Chong, Saar Gill, Jakub Svoboda, Katherine D. Cummins, Kimberly V. Amelsberg, Nicholas Yang, Inkook Chun, Seok Jae Hong, Hatcher J. Ballard, Ruchi Patel, Christopher Tor Sauter, Raymone Pajarillo, Guido Ghilardi, Puneeth Guruprasad, Yong Gu Lee
Chimeric antigen receptor T-cell (CART) immunotherapy led to unprecedented responses in patients with refractory/relapsed B-cell non-Hodgkin lymphoma (NHL); nevertheless, two thirds of patients experience treatment failure. Resistance to apoptosis is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36b0483ba6841122a031e009f0d25306
https://doi.org/10.1158/2159-8290.c.6549622.v1
https://doi.org/10.1158/2159-8290.c.6549622.v1
Autor:
Melody Smith, Anqi Dai, Guido Ghilardi, Kimberly V. Amelsberg, Sean M. Devlin, Raymone Pajarillo, John B. Slingerland, Silvia Beghi, Pamela S. Herrera, Paul Giardina, Annelie Clurman, Emmanuel Dwomoh, Gabriel Armijo, Antonio L. C. Gomes, Eric R. Littmann, Jonas Schluter, Emily Fontana, Ying Taur, Jae H. Park, Maria Lia Palomba, Elizabeth Halton, Josel Ruiz, Tania Jain, Martina Pennisi, Aishat Olaide Afuye, Miguel-Angel Perales, Craig W. Freyer, Alfred Garfall, Shannon Gier, Sunita Nasta, Daniel Landsburg, James Gerson, Jakub Svoboda, Justin Cross, Elise A. Chong, Sergio Giralt, Saar I. Gill, Isabelle Riviere, David L. Porter, Stephen J. Schuster, Michel Sadelain, Noelle Frey, Renier J. Brentjens, Carl H. June, Eric G. Pamer, Jonathan U. Peled, Andrea Facciabene, Marcel R. M. van den Brink, Marco Ruella
Publikováno v:
Nature Medicine.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::84c76e49b962bb0b05f019f3b4b8a6af
https://doi.org/10.1038/s41591-022-02069-7
https://doi.org/10.1038/s41591-022-02069-7
Autor:
Yong Gu Lee, Puneeth Guruprasad, Guido Ghilardi, Raymone Pajarillo, Christopher Tor Sauter, Ruchi Patel, Hatcher J. Ballard, Seok Jae Hong, Inkook Chun, Nicholas Yang, Kimberly V. Amelsberg, Katherine D. Cummins, Jakub Svoboda, Saar Gill, Elise A. Chong, Khrystyna North, Sarah E. Church, Joseph A. Fraietta, Wan-Jung Chang, Simon F. Lacey, Xueqing Maggie Lu, Yunlin Zhang, Kanupriya Whig, David C. Schultz, Sara Cherry, James Gerson, Stephen J. Schuster, Patrizia Porazzi, Marco Ruella
Publikováno v:
Cancer Discov
Chimeric antigen receptor T-cell (CART) immunotherapy led to unprecedented responses in patients with refractory/relapsed B-cell non-Hodgkin lymphoma (NHL); nevertheless, two thirds of patients experience treatment failure. Resistance to apoptosis is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d3478631319580234e2784ba61fc01d
https://europepmc.org/articles/PMC9547936/
https://europepmc.org/articles/PMC9547936/
Autor:
Srilakshmi Vallabhaneni, Srinath Adusumalli, Peter Groeneveld, James Gerson, Rupal P. O'Quinn
Publikováno v:
Journal of the American College of Cardiology. 81:2324
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8db63816c0a19e87704d57bccfa3b4e3
https://doi.org/10.1016/s0735-1097(23)02768-7
https://doi.org/10.1016/s0735-1097(23)02768-7
Autor:
Melody Smith, Anqi Dai, Guido Ghilardi, Kimberly V. Amelsberg, Sean M. Devlin, Raymone Pajarillo, John B. Slingerland, Silvia Beghi, Pamela S. Herrera, Paul Giardina, Annelie Clurman, Emmanuel Dwomoh, Gabriel Armijo, Antonio L. C. Gomes, Eric R. Littmann, Jonas Schluter, Emily Fontana, Ying Taur, Jae H. Park, Maria Lia Palomba, Elizabeth Halton, Josel Ruiz, Tania Jain, Martina Pennisi, Aishat Olaide Afuye, Miguel-Angel Perales, Craig W. Freyer, Alfred Garfall, Shannon Gier, Sunita Nasta, Daniel Landsburg, James Gerson, Jakub Svoboda, Justin Cross, Elise A. Chong, Sergio Giralt, Saar I. Gill, Isabelle Riviere, David L. Porter, Stephen J. Schuster, Michel Sadelain, Noelle Frey, Renier J. Brentjens, Carl H. June, Eric G. Pamer, Jonathan U. Peled, Andrea Facciabene, Marcel R. M. van den Brink, Marco Ruella
Publikováno v:
Nat Med
Anti-CD19 chimeric antigen receptor (CAR) T cell therapy has led to unprecedented responses in patients with high-risk hematologic malignancies. However, up to 60% of patients still experience disease relapse and up to 80% of patients experience CAR-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::652f668ef24deebfa0ecdc51fc4070ee
https://pubmed.ncbi.nlm.nih.gov/36253610
https://pubmed.ncbi.nlm.nih.gov/36253610
Publikováno v:
Developmental Biology. 290:277-286
Cell patterning in the vertebrate CNS reflects the combination of localized cell induction, migration and differentiation. A striking example of patterning is the myelination of visual system. In many species, retinal ganglion cell axons are myelinat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d83e79dee9add6c39d0a5818b39780b7
https://doi.org/10.1016/j.ydbio.2005.11.007
https://doi.org/10.1016/j.ydbio.2005.11.007